Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Non-Current Deffered Revenue (2016 - 2017)

Nephros has reported Non-Current Deffered Revenue over the past 7 years, most recently at $208000.0 for Q4 2017.

  • Quarterly results put Non-Current Deffered Revenue at $208000.0 for Q4 2017, down 25.18% from a year ago — trailing twelve months through Dec 2017 was $208000.0 (down 25.18% YoY), and the annual figure for FY2017 was $208000.0, down 25.18%.
  • Non-Current Deffered Revenue for Q4 2017 was $208000.0 at Nephros, down from $225000.0 in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for NEPH hit a ceiling of $531000.0 in Q1 2013 and a floor of $176000.0 in Q3 2013.
  • Median Non-Current Deffered Revenue over the past 5 years was $338500.0 (2015), compared with a mean of $333833.3.
  • Biggest five-year swings in Non-Current Deffered Revenue: plummeted 80.02% in 2013 and later skyrocketed 146.59% in 2014.
  • Nephros' Non-Current Deffered Revenue stood at $176000.0 in 2013, then skyrocketed by 136.93% to $417000.0 in 2014, then decreased by 16.79% to $347000.0 in 2015, then fell by 19.88% to $278000.0 in 2016, then fell by 25.18% to $208000.0 in 2017.
  • The last three reported values for Non-Current Deffered Revenue were $208000.0 (Q4 2017), $225000.0 (Q3 2017), and $243000.0 (Q2 2017) per Business Quant data.